Evidence map›Paper›PMID 31554970›Full record

ArticleNature2019

Analysis of the B cell receptor repertoire in six immune-mediated diseases.

R J M Bashford-Rogers, L Bergamaschi, E F McKinney, D C Pombal, F Mescia, J C Lee, D C Thomas, S M Flint, P Kellam, D R W Jayne and 2 more

Abstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. VDJ-REMIX: REpertoire Module Identification and eXploration.Bioinformatics (Oxford, England) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. AI-Driven BCR Modeling for Precision Immunology.International journal of molecular sciences · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

R J M Bashford-RogersDepartment of Medicine, University of Cambridge, Cambridge, UK. rbr1@well.ox.ac.uk.
L BergamaschiDepartment of Medicine, University of Cambridge, Cambridge, UK.
E F McKinneyDepartment of Medicine, University of Cambridge, Cambridge, UK.
D C PombalDepartment of Medicine, University of Cambridge, Cambridge, UK.
F MesciaDepartment of Medicine, University of Cambridge, Cambridge, UK.
J C LeeDepartment of Medicine, University of Cambridge, Cambridge, UK.
D C ThomasDepartment of Medicine, University of Cambridge, Cambridge, UK.
S M FlintDepartment of Medicine, University of Cambridge, Cambridge, UK.
P KellamDepartment of Medicine, Division of Infectious Diseases, Imperial College, London, UK.
D R W JayneDepartment of Medicine, University of Cambridge, Cambridge, UK.
P A LyonsDepartment of Medicine, University of Cambridge, Cambridge, UK.
K G C SmithDepartment of Medicine, University of Cambridge, Cambridge, UK. kgcs2@cam.ac.uk.

Funding

Medical Research Council MR/L019027/1Wellcome Trust 083650/Z/07/ZWellcome Trust 106068Wellcome Trust WT106068AIA
6 · The paper itself

Abstract

B cells are important in the pathogenesis of many, and perhaps all, immune-mediated diseases. Each B cell expresses a single B cell receptor (BCR)

Indexed as

AdultAgedClone CellsHumansImmune System DiseasesImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin IsotypesMiddle AgedReceptors, Antigen, B-CellYoung AdultImmunoglobulin AImmunoglobulin GImmunoglobulin IsotypesReceptors, Antigen, B-Cell

Identifiers

PMID31554970
PMCPMC6795535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.